共 96 条
[1]
Weenig RH(2007)Calciphylaxis: natural history, risk factor analysis, and outcome J Am Acad Dermatol 56 569-579
[2]
Sewell LD(2016)A nationally representative study of calcific uremic Arteriolopathy risk factors J Am Soc Nephrol 27 3421-3429
[3]
Davis MDP(2006)Symptomatic Management of Calciphylaxis : a case series and review of the literature J Pain Symptom Manag 32 186-190
[4]
McCarthy JT(2012)Calciphylaxis: A systematic review of existing and emerging therapies J Am Acad Dermatol 67 e253-e260
[5]
Pittelkow MR(2012)Calcific uremic Arteriolopathy on multimodal combination therapy: still unmet goal Int J Nephrol 2012 1-6
[6]
Nigwekar SU(2019)Treatment of Calciphylaxis in CKD: a systematic review and meta-analysis Kidney Int Reports 4 231-244
[7]
Zhao S(2013)Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data Kidney Blood Press Res 37 346-359
[8]
Wenger J(2015)Vitamin K antagonists predispose to Calciphylaxis in patients with end-stage renal disease Nephron. 129 197-201
[9]
Hymes JL(2017)Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review Br J Dermatol 177 1510-1518
[10]
Maddux FW(2001)A case of difficult pain in a patient with chronic renal failure and calciphylaxis J Pain Symptom Manag 22 617-621